Suppr超能文献

2019年冠状病毒病患者中,第二波疫情期间插管患者数量减少,但插管患者死亡率高于第一波疫情。

Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave.

作者信息

Routsi Christina, Kokkoris Stelios, Siempos Ilias, Magira Eleni, Kotanidou Anastasia, Zakynthinos Spyros

机构信息

All authors: First Department of Intensive Care Medicine, School of Medicine, National and Kapodistrian University of Athens, "Evangelismos" Hospital, Athens, Greece.

出版信息

Crit Care Explor. 2021 Oct 5;3(10):e531. doi: 10.1097/CCE.0000000000000531. eCollection 2021 Oct.

Abstract

UNLABELLED

Since changes in pharmacological treatments for severely ill patients with coronavirus disease 2019 have been incorporated into clinical practice, both by their use (corticosteroids and remdesivir) and by stopping them (e.g., hydroxychloroquine), we sought to compare the rate of intubation and mortality of intubated patients in our ICUs between the first and second waves of the pandemic.

DESIGN

Single-center, observational.

SETTING

Four coronavirus disease 2019 designated ICUs at an urban Greek teaching hospital.

PATIENTS

All adult patients with coronavirus disease 2019 consecutively admitted to ICU during the first ( = 50) and second ( = 212) waves of the pandemic.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

The percentage of intubated ICU patients dropped from 82% during the first wave to 66% during the second wave ( = 0.042). However, the absolute number of intubated ICU patients was lower during the first than the second wave (41 vs 140 patients). ICU or hospital mortality of intubated patients increased from 39% during the first wave to 60% during the second wave ( = 0.028). The binary logistic regression for hospital mortality as the dependent variable in intubated patients and covariates the age, Acute Physiology and Chronic Health Evaluation II score, cardiovascular comorbidity, lactate, positive end-expiratory pressure, Sequential Organ Failure Assessment score, and wave, distinguished only Acute Physiology and Chronic Health Evaluation II (odds ratio, 1.40 with 95% CI, 1.14-1.72; = 0.001) as the sole independent predictor of hospital mortality.

CONCLUSIONS

Pharmacological adaptations and other measures may have led to fewer intubations over time. However, these changes do not seem to be translated into improved outcomes of intubated patients. Perhaps the same change in the use of drugs and protocols that could cause fewer intubations of ICU patients might be a reason of increased mortality in those patients who are eventually intubated. Furthermore, the relative staff inexperience and overall increase in patients' comorbidities during the second wave could have contributed to increased Acute Physiology and Chronic Health Evaluation II score and mortality of intubated patients.

摘要

未标注

自2019冠状病毒病重症患者的药物治疗变化已纳入临床实践以来,无论是通过药物使用(皮质类固醇和瑞德西韦)还是停用药物(如羟氯喹),我们试图比较大流行第一波和第二波期间我们重症监护病房(ICU)中插管患者的插管率和死亡率。

设计

单中心观察性研究。

地点

希腊一家城市教学医院的四个2019冠状病毒病指定ICU。

患者

在大流行第一波(n = 50)和第二波(n = 212)期间连续入住ICU的所有成年2019冠状病毒病患者。

干预措施

无。

测量指标和主要结果

ICU插管患者的百分比从第一波期间的82%降至第二波期间的66%(P = 0.042)。然而,第一波期间ICU插管患者的绝对数量低于第二波(41例对140例患者)。插管患者的ICU或医院死亡率从第一波期间的39%升至第二波期间的60%(P = 0.028)。以医院死亡率为因变量、插管患者的年龄、急性生理与慢性健康状况评估II(APACHE II)评分、心血管合并症、乳酸、呼气末正压、序贯器官衰竭评估(SOFA)评分和波次为协变量的二元逻辑回归分析仅将APACHE II(比值比,1.40,95%置信区间为1.14 - 1.72;P = 0.001)作为医院死亡率的唯一独立预测因素。

结论

随着时间推移,药物调整和其他措施可能导致插管减少。然而,这些变化似乎并未转化为插管患者预后的改善。也许导致ICU患者插管减少的药物和方案使用方面的相同变化,可能是最终插管患者死亡率增加的一个原因。此外,第二波期间相对缺乏经验的医护人员以及患者合并症总体增加,可能导致APACHE II评分升高和插管患者死亡率增加。

相似文献

1
Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave.
Crit Care Explor. 2021 Oct 5;3(10):e531. doi: 10.1097/CCE.0000000000000531. eCollection 2021 Oct.
3
Outcome Improvement Between the First Two Waves of the Coronavirus Disease 2019 Pandemic in a Single Tertiary-Care Hospital in Belgium.
Crit Care Explor. 2021 May 19;3(5):e0438. doi: 10.1097/CCE.0000000000000438. eCollection 2021 May.
7
Interventions and outcomes of COVID-19 patients in a community hospital-A single center study comparing the first and second waves.
PLoS One. 2022 Dec 16;17(12):e0279208. doi: 10.1371/journal.pone.0279208. eCollection 2022.

本文引用的文献

1
Have we improved the management of COVID-19 patients admitted in intensive care between the two waves?
J Crit Care. 2021 Oct;65:84-85. doi: 10.1016/j.jcrc.2021.05.022. Epub 2021 Jun 5.
5
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
6
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验